US2011244053A1PendingUtilityA1

Use a goat serum for veterinary treatment

Assignee: PECK GRAHAM JOSEPHPriority: Nov 12, 2003Filed: Jun 9, 2011Published: Oct 6, 2011
Est. expiryNov 12, 2023(expired)· nominal 20-yr term from priority
A61P 35/00A61P 25/00A61P 29/00A61P 11/00A61P 17/00A61P 11/06C07K 16/114C07K 2317/20A61K 39/39516A61K 2039/505A61K 38/00C07K 16/06C07K 16/2833A61K 39/42
32
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for veterinary treatment of mammals are described, for treatment of conditions having an inflammatory component. The methods are particularly suited to treatment of cats, dogs, or horses.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A method of veterinary treatment of a mammal for an inflammatory respiratory disease, comprising administering a serum composition obtained from a goat after challenge with HIV, wherein the inflammatory respiratory disease is selected from the group consisting essentially of canine bronchitis, chronic airway disease, fibrosing alveolitis, feline asthma, and equine respiratory disorders. 
     
     
         14 . The method of  claim 13  wherein the mammal is a canine. 
     
     
         15 . The method of  claim 14  wherein the disease is canine bronchitis. 
     
     
         16 . The method of  claim 13  wherein the mammal is a feline. 
     
     
         17 . The method of  claim 16  wherein the disease is feline asthma. 
     
     
         18 . The method of  claim 13  wherein the mammal is an equine. 
     
     
         19 . The method of  claim 18  wherein the disease is chronic obstructive pulmonary disease. 
     
     
         20 . The method of  claim 13  wherein the disease is chronic airway disease. 
     
     
         21 . The method of  claim 13  wherein the disease is fibrosing alveolitis.

Join the waitlist — get patent alerts

Track US2011244053A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.